Press Releases

Date	Title	PDF Version
Sep 23, 2011	Soliris® (eculizumab) Approved by FDA for All Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Sep 23, 2011	Alexion Receives CHMP Positive Opinion for Soliris® (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the European Union
Sep 14, 2011	Phase 2 Study of Eculizumab (Soliris®) in Patients with Severe and Refractory Generalized Myasthenia Gravis Presented at MGFA Annual Meeting
Sep 14, 2011	Alexion to Present at the UBS Global Life Sciences Conference
Sep 06, 2011	Alexion to Present at the Morgan Stanley Global Healthcare Conference
Aug 31, 2011	Alexion to Present at the Stifel Nicolaus Healthcare Conference 2011
Jul 26, 2011	Alexion Pharmaceuticals Partners with the Connecticut Community Foundation to Award Scholarships to Eight Waterbury, Connecticut Public High School Graduates
Jul 21, 2011	Alexion Reports Second Quarter 2011 Results
Jul 07, 2011	Alexion Pharmaceuticals to Report Second Quarter 2011 Results on Thursday, July 21, 2011
Jun 20, 2011	Alexion Initiates Clinical Trial of Eculizumab as a Potential Treatment for Patients with STEC-HUS in Expanded Response to EHEC Crisis in Germany

Search